Infants with Short Bowel Syndrome May Benefit from Enteral Fish Oil
Enteral fish oil may be an effective adjunctive treatment for infants with parenteral nutrition-associated liver disease (PNALD). In this retrospective case series, 6 infants (average age 5 +/- 2.6 weeks ) with short bowel syndrome and PNALD were treated with enteral fish oil supplementation and evaluated over a 12 week period. Within a range of 2 - 8 weeks, elevated total bilirubin levels were completely reversed in four of the six infants. In addition, improvement in enteral feedings occurred after starting enteral fish oil therapy. These results suggest that enteral feeding with fish oil may benefit infants with nutrition-associated liver disease and short-bowel syndrome.
Click Here to visit the journal website. Subscription required to view the full text of the article.